What is Brief History of Option Care Health Company?

What is the history of Option Care Health?

Option Care Health is a major player in home and alternate site infusion services, changing how patients get vital treatments. It started in 1979 in Chico, California, with a goal to offer medical care outside hospitals for better patient results and convenience.

Founded by two pharmacists, the company initially focused on home nutritional feedings, a novel idea then. This approach met a key healthcare need, enabling patients to manage serious conditions at home.

What is Brief History of Option Care Health Company?

Option Care Health has grown immensely since its start. It now serves as the largest independent provider of home and alternate site infusion services nationwide, operating in all 50 states. The company's expansion showcases its successful evolution from a local service to a national healthcare leader. In 2024, Option Care Health achieved net revenues between $4.99 billion and $5.00 billion, marking a significant growth of 16.0% to 16.2% compared to the prior year. This impressive financial performance, supported by a team of over 8,000 members including more than 5,000 clinicians, highlights its substantial market presence and the success of its innovative care model, which includes services like those analyzed in the Option Care Health BCG Matrix.

The Option Care Health company history began in 1979, founded by two pharmacists, Michael Prime and Mitchell Hoggard, in California. Their vision was to provide essential medical treatments directly to patients in their homes, addressing a clear need for more accessible and convenient healthcare solutions.

The Genesis of Home Infusion

The Option Care Health background is rooted in a specific patient need. A young accident victim required daily intravenous nutritional feedings, and the frequent hospital visits highlighted a gap in care delivery. This experience inspired the founders to develop a home-based alternative.

• Founded in 1979 by Michael Prime and Mitchell Hoggard.
• Initial focus on preparing and delivering sterile intravenous nutritional solutions for home use.
• Pioneered home care as a more affordable alternative to hospital stays.
• Expanded services to include antibiotics, chemotherapy, hydration, and pain management therapies.

Initially operating under the name CliniCare, the company focused on preparing and delivering sterile nutritional intravenous solutions for home administration. After successfully serving their first two patients, they began marketing their services to physicians in the Chico area, emphasizing home care as a more affordable alternative to hospital stays. This approach led to increased referrals for various intravenous therapies, including antibiotics, chemotherapy, hydration, and pain control, marking a significant step in the Option Care Health evolution.

The company's initial funding sources are not explicitly detailed, but their early operations suggest a bootstrapping approach, growing from direct patient care and expanding services based on demand. An interesting aspect of the Option Care Health company timeline involves its name change. The initial name, CliniCare, had to be changed due to prior registration. In 1983, the company adopted the name O.P.T.I.O.N. (Outpatient Parenteral Therapy and Intravenous Ongoing Nutrition) Care, a descriptive acronym that articulated their services. This was later simplified to just 'Option Care' in the early 1990s. The cultural and economic context of the late 1970s and early 1980s, marked by a growing emphasis on cost-effective healthcare solutions and a desire for patient-centric care, significantly influenced the company's creation and its vision for home-based infusion therapy, contributing to the Brief History of Option Care Health.

Complete Option Care Health Strategy Bundle

• 6 Full Frameworks, 1 Company – All Pre-Researched
• Each Framework Fully Sourced with Real Company Data
• Built for Strategy Courses, Case Studies & MBA Programs
• Adapt to Your Assignment – No Starting from Scratch
• 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's

GET FULL BUNDLE

The journey of Option Care Health began in 1980 as CliniCare, with founders Hoggard and Prime laying the groundwork for the home infusion market. The company's evolution saw a name change to O.P.T.I.O.N. Care in 1983, followed by a significant partnership with Sutter Community Hospital in 1984, providing essential capital for expansion.

Early Foundation and Rebranding

Established in 1980 as CliniCare, the company's initial phase focused on building its presence in the nascent home infusion sector. By 1983, following the establishment of license agreements, the company was renamed O.P.T.I.O.N. Care, marking a key step in its corporate identity.

Strategic Partnerships and Market Penetration

A pivotal moment in the Option Care Health background occurred in 1984 with the sale of two-thirds of the company to Sutter Community Hospital, injecting vital capital. The subsequent year, 1985, saw a deliberate push for growth through the hiring of franchise salespeople and targeted advertising in national healthcare publications.

Acquisition and Private Equity Transition

The Option Care Health company overview includes its acquisition by Walgreens in 2007, integrating its services into a larger retail pharmacy network. This was followed by a significant shift in 2015 when Walgreens divested Option Care to Madison Dearborn Partners, a private equity firm, initiating a new chapter of independent growth.

Merger and Rebranding to Option Care Health

A major milestone in the Option Care Health history was the 2019 merger with BioScrip, Inc., creating a leading independent provider of home and alternate site infusion services. This strategic combination led to the rebranding as Option Care Health, Inc. in 2020, underscoring a commitment to enhanced patient care.

The company's expansion strategy has consistently involved broadening its service offerings, moving beyond nutritional support to encompass a wide array of therapies and clinical programs. This growth is evidenced by its substantial physical footprint, operating over 170 locations and more than 90 pharmacies with 750 infusion suite chairs as of June 2025. Strategic pharmacy network expansions in key regions, such as New York, Tampa, and Richmond, have further solidified its market presence. The increasing acceptance of home infusion services, driven by advancements in specialty drugs and payer preferences for home-based care, has created a favorable environment for companies like Option Care Health. Understanding the competitive landscape is crucial, and a look at the Competitors Landscape of Option Care Health provides further context on its market positioning.

From PESTLE Factors to Full Strategy Bundle

• PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
• Every Strategic Angle Covered – Nothing Left to Research
• Pre-filled with Company-Specific Research
• No Missing Sections for Your Case Study
• One Download Covers Your Entire Company Analysis

GET COMPLETE BUNDLE

The Option Care Health company history is a narrative of pioneering home infusion therapy, strategic expansion, and adaptation to industry challenges. From its inception, the company has focused on bringing critical medical services directly to patients' homes, evolving significantly through mergers and technological integration.

Innovations have been central to the company's growth, starting with the very concept of home infusion therapy. More recently, the company has focused on expanding its service delivery capacity and exploring advanced technologies like AI and machine learning to improve patient care and operational efficiency.

Home Infusion Therapy Pioneering

The company's origin lies in the groundbreaking delivery of nutritional support to patients at home, a novel approach in 1979.

National Scale Expansion

The merger with BioScrip significantly broadened its reach, enabling service provision across all 50 states.

Service Delivery Capacity Growth

The substantial increase in infusion suites from 43 in 2022 to 84 in 2023 demonstrates a commitment to enhanced patient access.

Technological Integration

Investments in AI and machine learning signal a forward-looking approach to service enhancement and operational improvements.

Strategic Partnerships

Active pursuit of partnerships with manufacturers and channel partners aims to broaden the company's therapy portfolio.

Financial Resilience Strategies

The implementation of share repurchase programs demonstrates a strategy to manage financial performance and return value to shareholders.

The company has encountered challenges, including disruptions from natural events like Hurricane Helene in late 2024, which impacted supply chains for intravenous solution bags. Additionally, anticipated negative gross profit impacts of $60 million to $70 million in 2025 due to Stelara pricing adjustments highlight the ongoing need for financial agility.

Supply Chain Disruptions

Hurricane Helene in late 2024 caused significant supply chain disruptions, affecting the availability of essential intravenous solution bags.

Drug Pricing Adjustments

The company anticipates a notable financial impact from pricing changes related to specific therapies, requiring careful financial planning.

Competitive Market Pressures

Navigating a competitive healthcare landscape requires continuous adaptation and strategic positioning to maintain market share.

Operational Scaling Challenges

Rapid growth and expansion in service capacity can present logistical and operational hurdles that need efficient management.

Regulatory Environment

Adhering to evolving healthcare regulations and reimbursement policies is a constant challenge for providers in this sector.

Patient Access and Equity

Ensuring equitable access to high-quality home infusion services for all eligible patients remains a critical operational and ethical consideration.

Option Care Health Business Model + Strategy Bundle

• Ideal for Essays, Case Studies & Slides
• Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
• Company-Specific Content Already Organized
• One Bundle Replaces Days of Independent Research
• Buy the Bundle Once. Use Across All Your Assignments

GET COMPLETE ANALYSIS

The Option Care Health company history is a story of innovation and strategic growth in the home infusion therapy sector. From its beginnings as CliniCare in 1979, the company has undergone significant transformations, including name changes, ownership shifts, and a pivotal merger, to become a leader in its field. This evolution reflects a commitment to adapting and expanding its services to meet patient needs.

Market Leadership and Growth Projections

Option Care Health is a significant player in the home and alternate site infusion market, estimated at $18-$20 billion. The company holds an impressive 25%-30% market share.

Financial Outlook for 2025

For the full year 2025, Option Care Health anticipates net revenue between $5.4 billion and $5.6 billion. Adjusted diluted earnings per share are projected from $1.61 to $1.70, with adjusted EBITDA expected between $455 million and $470 million.

Strategic Initiatives for the Future

Future strategies include investing in AI and machine learning, expanding infusion clinics, and capitalizing on market opportunities as competitors withdraw from certain segments. The company also plans continued capital deployment through M&A and share repurchases.

Adapting to Market Dynamics

Option Care Health is prepared for evolving drug pricing and anticipates increased payer interest in site-of-care initiatives, which strongly favors home infusion. This aligns with the company's founding vision of providing accessible, high-quality care in preferred patient settings.

From Five Forces to Full Company Analysis

• Includes SWOT, PESTLE, BMC, BCG and 4P's
• Pre-Researched with Company-Specific Data
• Best Value for a Complete Analysis
• Ready to Adapt for Your Case Study
• Ready for Essays and Slidesd

GET FULL BUNDLE